Commercialization of Organoids.

Affiliation

Choudhury D(1), Ashok A(2), Naing MW(2).
Author information:
(1)Bio-Manufacturing Group, Singapore Institute of Manufacturing Technology
(SIMTech), Agency for Science, Technology, and Research
(A*STAR), 2 Fusionopolis Way, #08-04, Innovis, Singapore. Electronic address: [Email]
(2)Bio-Manufacturing Group, Singapore Institute of Manufacturing Technology
(SIMTech), Agency for Science, Technology, and Research
(A*STAR), 2 Fusionopolis Way, #08-04, Innovis, Singapore.

Abstract

Organoids have been successfully exploited for drug screening, disease modeling, pathogenesis, and regenerative medicine. Herein, we discuss the progress achieved in the commercialization of organoids in the last few years. We further elaborate on the concept of organoid biobank and highlight ethical and regulatory issues surrounding organoid research and commercialization.

OUR Recent Articles